OBIO Financials
Orchestra BioMed Holdings Inc. - Financial statements & key metrics
Stock Price
$5.04
Market Cap
$231.74M
P/E Ratio
-3.0
EPS
$-1.80
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$2.64M
Gross Profit
-
Operating Income
-
Net Income
$-61.02M
EPS (Diluted)
$-1.66
Balance Sheet Highlights
Total Assets
$76.17M
Total Liabilities
$43.22M
Shareholders Equity
-
Cash & Equivalents
$22.26M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-50.56M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Operating Margin
-2359.2%
ROE
-167.0%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is OBIO revenue?
OBIO's most recent quarterly revenue was $2.64M. Annual revenue can be calculated by summing the four most recent quarters.
Is OBIO profitable?
OBIO reported a loss of $61.02M in the most recent quarter.
What is OBIO market cap?
OBIO has a market capitalization of $231.74M, making it a small-cap stock.
Does OBIO have debt?
View OBIO's balance sheet for debt information.
What is OBIO cash flow?
Cash flow data is available in the full financial statements.